News and Events

Join Chemspace & Shanghai Institute of Materia Medica 'Intelligent DNA Encoded Library (iDEL) Technology for Small Molecule Drug Discovery', which will take place at 5:00 PM (CET) / 8:00 AM (PST) on July 1st, 2021.

We are happy to announce our new campaign about DNA-encoded libraries (DELs).

The first post is an overview of this topic based on the paper published last January.

Heterocyclic Alkyl Halides are the Molecules of This Week!

We at Chemspace always have new small molecules to power up your research.

To browse the set please use this link.

This May, a group of researchers published a miniperspective on the importance of isosteres for epigenetic drug discovery. They summed up the frequency of various post-translationally modified lysine bioisosteres found in different compound collections, discovering general trends.

We at Chemspace prepared 3 great sets of compounds based on oxazole, triazole and pyridone moieties!

Dear friends and colleagues!

Thanks to everyone for joining the Chemspace & MedChemExpress Webinar 'MedChemExpress: dedicated to enabling your success in biomedical research and drug discovery' yesterday!

For those who didn’t have a chance to connect, the recording is already available!

Dear friends and colleagues!

Join Chemspace & MedChemExpress Webinar 'MedChemExpress: dedicated to enabling your success in biomedical research and drug discovery', which will take place at 5:00 PM (CET)/8:00 AM (PST) TOMORROW, on June 17th, 2021.

The Speaker is Dr. Wei Li (Devid Li), Vice President at MedChemExpress.

Register via the link now!

We are happy to continue our new video series - Chemspace Tutorials.

Enjoy the Second Video!

We are happy to continue our new inspired by Drug Hunter’s “Small Molecules of the Month” series!

Here are two molecules that were recently highlighted by Drug Hunter!

Isocyanates are the Molecules of This Week!

We at Chemspace always have new small molecules to power up your research.

To browse the set please use this link.

This May, a group of researchers published an article 'Novel irreversible covalent BTK inhibitors discovered using DNA-encoded chemistry'.

The paper describes synthesis of multiple DNA-encoded chemical libraries (DECL) for discovering covalent inhibitors.

At Chemspace, we offer In-Stock Covalent Modifiers library (>200K) from our Selected Screening set and also we provide Ready to use self-serve product from HitGen Inc. - OpenDEL®:  “OpenDEL® - Billions in A Vial!” - 1 Billion compound set.

Meet Chemspace Monthly Digest! 

Here is a summary of all Chemspace news and highlights for May in case you have missed them!

This May, Infigratinib (TRUSELTIQ) received approval by the FDA for adults treatment of cholangiocarcinoma.

It is an ATP-competitive, FGFR1-3 tyrosine kinase inhibitor implicated in origin of FGFR-driven diseases.

Infigratinib contains dihalogen dimethoxy aniline moiety in its backbone.

We have made a set of Building Blocks, which contain similar parts – the perfect start for your research!

Dear friends and colleagues!

Thanks to everyone for joining the Chemspace & Key Organics Webinar 'Key Organics Chemistry Solutions: Synthesis, building blocks, fragments and PROTACs' yesterday!

For those who didn’t have a chance to connect, the recording is already available!

Dear friends and colleagues!

Join Chemspace & Key Organics Webinar 'Key Organics Chemistry Solutions: Synthesis, building blocks, fragments and PROTACs', which will take place at 5:00 PM (CET) / 8:00 AM (PST) TOMORROW on May 26th, 2021.

The Speaker is Dr. Steve Brough, Business Development Manager at Key Organics.

Register via the link now!

Aryl Halides are the Molecules of This Week! We at Chemspace always have new small molecules to power up your research. To browse the set please use this link.

We are happy to continue our new inspired by Drug Hunter’s “Small Molecules of the Month” series!

Here are three molecules that were recently highlighted by Drug Hunter!

Last June, a group of researchers published a Perspective 'Fragment linking strategies for structure-based drug design'.

This exhaustive view describes usage of different approaches in fragment-based drug discovery (FBDD) - growing, linking, and merging - in design and synthesis of nearly 50 drugs and clinical candidates.

We at Chemspace offer 11 "In-Stock" Fragment Compound Sets!

Dear friends and colleagues!

Join Chemspace & Key Organics Webinar 'Key Organics Chemistry Solutions: Synthesis, building blocks, fragments and PROTACs', which will take place at 5:00 PM (CET) / 8:00 AM (PST) on May 26th, 2021.

The Speaker is Dr. Steve Brough, Business Development Manager at Key Organics.

Register via the link now!

Trilacicilib (COSELA) received approval by the FDA in February 2021 as a drug to reduce the frequency of chemotherapy-induced bone marrow suppression in adults receiving certain types of chemotherapy for extensive-stage small cell lung cancer (SCLC).

Trilacicilib contains diazaspiro[5.5]undecan-3-one moiety in its backbone.

We have made a set of Building Blocks, which contain similar parts – the perfect start for your research!

Dear friends and colleagues!

Thanks to everyone for joining the  Chemspace & AnalytiCon Discovery Webinar 'Leveraging Natural Product based Chemical Spaces' yesterday!

For those who didn’t have a chance to connect, the recording is already available!

Join Chemspace & AnalytiCon Discovery Webinar 'Leveraging Natural Product based Chemical Spaces', which will take place at 5:00 PM (CET) / 8:00 AM (PST) TODAY, on May 11th, 2021.

The Speaker is Dr. Lars Ole Haustedt, Director Projects & Innovation at AnalytiCon Discovery.

Meet Chemspace Monthly Digest! 

Here is a summary of all Chemspace news and highlights for April in case you have missed them!

ChemFaces is Chemspace reliable supplier which we are happy to recommend it to you preferably.

ChemFaces is a professional high-purity natural products and phytochemical reference materials manufacturer.

Now they have more than 2000 products with good quality are provided with special offer up to 50% off.

Thiols are the Molecules of This Week! We at Chemspace always have new small molecules to power up your research. To browse the set please use this link.

Tivozanib (FOTIVDA) received approval by the FDA in March 2021 as a drug for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC).

Tivozanib contains 1,2-oxazole moiety in its backbone.

We have made a set of Building Blocks, which contain such parts with an amine group in different positions – the perfect start for your research!